# Lineage Cell Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Nov 14, 2025

- Company: [Lineage Cell Therapeutics, Inc.](/companies/lctx.md) (CIK 876343)
- Form: SCHEDULE 13D/A
- Filed: 2025-11-14
- Accepted by EDGAR: Nov 14, 2025, 18:12 ET
- Period: not reported
- Accession: 0000919574-25-007051
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/876343/000091957425007051/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/876343/000091957425007051/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/876343/000091957425007051/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Nov 14, 2025.
Source: SEC EDGAR, the filing index for accession 0000919574-25-007051. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.